600664 哈药股份
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)5.97012.4858.73311.38010.129
总资产报酬率 ROA (%)2.2904.3782.8703.5403.006
投入资产回报率 ROIC (%)3.6436.9624.7745.9495.068

边际利润分析
销售毛利率 (%)26.02428.24426.21424.66623.715
营业利润率 (%)4.0405.5034.2685.0395.018
息税前利润/营业总收入 (%)4.2385.6384.3885.5675.668
净利润/营业总收入 (%)2.8424.2693.0683.7093.201

收益指标分析
经营活动净收益/利润总额(%)106.30899.60499.74275.19065.969
价值变动净收益/利润总额(%)0.0611.4210.6895.7510.135
营业外收支净额/利润总额(%)-0.970-1.737-1.3970.763-1.884

偿债能力分析
流动比率 (X)1.4451.3551.2611.1951.112
速动比率 (X)1.1591.1211.0280.9690.849
资产负债率 (%)54.49358.33861.57363.18165.579
带息债务/全部投入资本 (%)29.71339.38140.23139.95742.922
股东权益/带息债务 (%)222.214143.476136.601136.023116.798
股东权益/负债合计 (%)73.73762.74354.36750.98545.681
利息保障倍数 (X)17.95224.62024.47211.3717.632

营运能力分析
应收账款周转天数 (天)102.47597.86299.228104.846105.910
存货周转天数 (天)60.29259.16658.84566.92872.352